Close up portrait of Emmanuelle Coutanceau

Emmanuelle Coutanceau, Ph.D.

Member – Novo Holdings

Dr. Coutanceau has served on our board of directors since October 2019. Dr. Coutanceau has over 14 years of experience in venture capital investment in the life sciences space. She joined Novo Holdings A/S in September 2015 and has been employed as a Partner there since January 2018. Dr. Coutanceau currently serves on the board of directors of CorWave SA, a biomedical engineering company, Minervax ApS, a clinical-stage vaccine company, and HepaRegeniX GmbH, a preclinical-stage company for the treatment of liver diseases, as well as the boards of several other private life sciences companies. Dr. Coutanceau received a Master degree in Agronomic Science and Technology from Agrocampus Ouest and a Ph.D. in Microbiology from University of Paris. She also has a Specialized Master degree in pharmaceutical management from ESCP Business School.